Loading...
A Substantial Response from Adding Palbociclib to Endocrine Therapy in Brain Metastasis from Hormone Receptor-Positive, HER2-Negative Breast Cancer: Case Reports
Brain metastasis (BM) from breast cancer has poor prognosis despite new advances and multi-modality treatments. No current data is guiding the use of palbociclib in the management of hormone receptor (HR)-positive breast cancer patients with BM as these patients were excluded systematically from all...
Na minha lista:
| Udgivet i: | Case Rep Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983625/ https://ncbi.nlm.nih.gov/pubmed/33790765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000514190 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|